Several reports have described the presence of giant platelets in patients
with type 2B von Willebrand disease (VWD). We have now characterized the ul
trastructural changes in platelets from three unrelated patients with type
2B VWD and different mutations within exon 28 of the von Willebrand factor
(VWF) gene. Electron microscopy showed that each of these subjects had an i
ncreased proportion of large platelets when compared with those of a patien
t with type 2A VWD or control subjects. Immunogold labelling for VWF was pe
rformed. Large masses detected by anti-VWF antibody were seen not only on t
he platelet surface, but also inside the platelet surface-connected canalic
ular system (SCCS) when ultrathin sections were labelled. This suggested tr
anslocation of the abnormally bound VWF from the platelet surface. Labellin
g of the or-granules was eccentric as for normal platelets. Labelling for g
lycoprotein (Gr) Ib was seen on the surface and within the SCCS, suggesting
co-localization with the bound VWF. However, there was no evidence for VWF
in endosomes or other endocytic vesicles. The presence of platelet-bound V
WF was not accompanied by high levels of platelet activation, as detected b
y electron microscopy, or by using monoclonal antibodies against P-selcctin
or activation-dependent determinants on GP IIb-IIIa in flow cytometry. Int
riguingly, platelet ultrastructure often resembled that seen in patients wi
th congenital thrombocytopathies characteristic of giant platelet syndromes
.